FDA NDC Directory · JSON-LD · Markdown

Deflazacort Oral Suspension

NDC 70710-2007 · HUMAN PRESCRIPTION DRUG · SUSPENSION

Generic nameDeflazacort
Labeler / ManufacturerZydus Pharmaceuticals (USA) Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA220042
Dosage form / routeSUSPENSION · ORAL
Active ingredientsDEFLAZACORT (22.75 mg/mL)
Marketing started20251023
Package count1

External sources

Source: openFDA. Public-domain (CC0).